Share on PinterestSputnik V shows promise in post-registration trials in Russia.Photo credit: Natalia Kolesnikova/AFP via Getty ImagesFirstly, scientists at the Gamaleya Research Institute of Epidemiology and Microbiology, in Moscow, devised a vaccine that elicits a robust immune response, with no serious side effects in humans. The last few weeks also saw the development of a…
By Michael Le Page , Clare Wilson , Jessica Hamzelou , Adam Vaughan , Conrad Quilty-Harper and Layal Liverpool Sputnik V, Gamaleya National CenterTHE RUSSIAN DIRECT INVESTMENT FUND Latest coronavirus news as of 5 pm on 4 September Russia’s vaccine candidate produced antibody and T-cell responses in early-stage trial A preliminary trial of Russia’s coronavirus…
By Michael Le Page Denis Rebrikov says he will still move forward with gene-editing work to prevent heritable deafnessAndrey Rudakov/Bloomberg via Getty Russian biologist Denis Rebrikov has told New Scientist that he still plans to use CRISPR genome editing to prevent children inheriting deafness, despite a major international report out today saying it isn’t yet…
5 min read WHEN THE JUSTICE Department released a trove of Epstein-related files on January 30 and then pulled down thousands of pages after redaction failures exposed victims’ identifying information and explicit material, I felt a familiar gut-drop. Once again, the people with the least power were being asked to pay twice—first for the abuse
You don't have permission to access "http://www.medpagetoday.com/obgyn/hrt/119940" on this server. Reference #18.5bf4d517.1771491743.1e0de1 https://errors.edgesuite.net/18.5bf4d517.1771491743.1e0de1
It’s the rare policy question that unites Republican Gov. Ron DeSantis of Florida and the Democratic-led Maryland government against President Donald Trump and Gov. Gavin Newsom of California: How should health insurers use AI? Regulating artificial intelligence, especially its use by health insurers, is becoming a politically divisive topic, and it’s scrambling traditional partisan lines.